---
title: "Danaher Q2 FY26 net earnings rise 60% to $870 million; revenue increases 5.5% to $6.3 billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293322586.md"
description: "Danaher reported Q2 FY26 net earnings of $870 million, a 60% year-over-year increase, with revenue rising 5.5% to $6.3 billion. Non-GAAP adjusted diluted EPS grew 8.0% to $1.94. The company raised its full-year 2026 adjusted diluted EPS outlook to $8.45-$8.60 and forecast Q3 non-GAAP core revenue growth of 2.0%-3.0%, citing strong performance in Life Sciences."
datetime: "2026-07-21T10:02:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293322586.md)
  - [en](https://longbridge.com/en/news/293322586.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293322586.md)
---

# Danaher Q2 FY26 net earnings rise 60% to $870 million; revenue increases 5.5% to $6.3 billion

-   Danaher posted Q2 2026 net earnings of USD 870 million, up 60% year-over-year; diluted EPS rose to USD 1.23. \* Revenue increased 5.5% from a year earlier to USD 6.3 billion; non-GAAP core revenue climbed 3.0%. \* Non-GAAP adjusted diluted EPS grew 8.0% to USD 1.94; operating cash flow was USD 1.5 billion. \* Non-GAAP free cash flow totaled USD 1.3 billion; CEO Rainer M. Blair said Life Sciences had its strongest quarter in several years. \* Forecast Q3 non-GAAP core revenue growth of 2.0%-3.0%; raised 2026 adjusted diluted EPS outlook to USD 8.45-8.60. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Danaher Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607210600PR\_NEWS\_USPR\_\_\_\_\_PH08531) on July 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [DHR.US](https://longbridge.com/en/quote/DHR.US.md)

## Related News & Research

- [Key facts: Danaher strong cash; trims 2026 outlook; bio orders, $100M deferred](https://longbridge.com/en/news/293434927.md)
- [Danaher unit Cepheid unveils third-generation GeneXpert system at ADLM 2026](https://longbridge.com/en/news/293477376.md)
- [Stock Of The Day: Is The Danaher Selloff Over?](https://longbridge.com/en/news/293517409.md)
- [Royal Bank of Canada Has $625.59 Million Position in Danaher Corporation $DHR](https://longbridge.com/en/news/294186660.md)
- [BUZZ-Street View: Bioprocess woes weigh on Danaher, but bulls stay put](https://longbridge.com/en/news/293441431.md)